Electromed, Inc.ELMDNYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank85
5Y CAGR+61.5%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
+61.5%/yr
Long-term compound
Percentile
P85
Within normal range
vs 5Y Ago
11x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 59.34% |
| Q3 2025 | -20.20% |
| Q2 2025 | 9.03% |
| Q1 2025 | 10.36% |
| Q4 2024 | 51.20% |
| Q3 2024 | -5.68% |
| Q2 2024 | 5.39% |
| Q1 2024 | 56.07% |
| Q4 2023 | -48.06% |
| Q3 2023 | -30.87% |
| Q2 2023 | 79.52% |
| Q1 2023 | 7.79% |
| Q4 2022 | -48.32% |
| Q3 2022 | -5.40% |
| Q2 2022 | -6.25% |
| Q1 2022 | 2.13% |
| Q4 2021 | -12.50% |
| Q3 2021 | 15.25% |
| Q2 2021 | -19.84% |
| Q1 2021 | -19.72% |
| Q4 2020 | 5.41% |
| Q3 2020 | 15.84% |
| Q2 2020 | 5.94% |
| Q1 2020 | 173.19% |
| Q4 2019 | 45.02% |
| Q3 2019 | -7.12% |
| Q2 2019 | -37.62% |
| Q1 2019 | -28.20% |
| Q4 2018 | 248.79% |
| Q3 2018 | -16.15% |
| Q2 2018 | 90.60% |
| Q1 2018 | -24.88% |
| Q4 2017 | -19.63% |
| Q3 2017 | 9.35% |
| Q2 2017 | -19.84% |
| Q1 2017 | -20.03% |
| Q4 2016 | -71.27% |
| Q3 2016 | 77.78% |
| Q2 2016 | 133.80% |
| Q1 2016 | 47.85% |